Eli Lilly, which introduced the Lilly Insulin Value Program $35 co-pay card in April 2020 to help people struggling financially during the COVID-19 crisis, today announced the program has been added to the company's comprehensive suite of insulin affordability solutions. Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.
The copay card is being added to Lilly's suite of solutions to help people with high-deductible insurance plans who otherwise face challenging out-of-pocket costs and those who don't have insurance because of their income or job status.
"No one should ever have to ration their insulin. That's why we are committed to including the copay card in our ongoing suite of solutions," said Mike Mason, president of Lilly Diabetes. "Making insulin affordable at pharmacies through programs like the Lilly Insulin Value Program helps reduce the financial burden some people face at the pharmacy counter."
The co-pay card can be accessed immediately through the Lilly Diabetes Solution Center. Numerous programs, such as help for people with immediate needs, automatic caps at retail pharmacies and donations to nonprofit organizations like Lilly Cares, are helping up to 20,000 people each month access Lilly insulins at lower costs. The $35 co-pay card can be accessed by calling the Solution Center at (833) 808-1234 or by downloading the co-pay card here.
Earlier this year, Lilly announced plans to make its insulins available through the Medicare Part D Senior Savings Model, allowing seniors to purchase their monthly prescriptions for $35. Collectively, the Lilly Insulin Value Program and Medicare Part D Senior Savings Model provide options for anyone using Lilly insulin to purchase their monthly prescription at retail pharmacies for $35 starting in January 2021.
"Shifting costs from healthy people to those with chronic conditions such as diabetes is a persistent trend that must be reversed," Mason said. "The Part D Senior Savings Model is a solution-oriented approach to a problem that has affected seniors for a long time. This program will help people living with diabetes who use insulin."
Lilly also provides penny-priced insulin to all 340B covered entities. Additionally, following the Administration's recent executive order requiring Federally Qualified Health Centers to pass 340B discount pricing for insulin onto patients, Lilly announced last week that it will continue selling insulin at 340B prices to only those contract pharmacies that agree to pass discounts onto patients with no markups, dispensing fees or duplicate billing.
Today's announcement ties to the start of a new awareness program launched by Lilly. Throughout the program — Insulin Affordability: Learn, Act, Share — Lilly will collaborate with numerous national, state and local organizations to educate people using Lilly insulin on how to take action and save money at the pharmacy.
"We've launched this awareness initiative as part of our ongoing commitment to help people using Lilly insulin access it at an affordable out-of-pocket cost," said Adrienne Brown, vice president of U.S. Connected Care & Insulins. "Although we offer several affordability programs, we know there are people who have not taken action to get help. Our goal is to encourage people who use Lilly insulin and need help to take actions that may lower their out-of-pocket costs at the pharmacy."